- ►ecmaj.ca CJ Maxwell, DB Hogan, EM Ebly - Canadian Medical Association Journal, 1999 - ecmaj.ca Results: The proportion of subjects whose cognitive performance declined over
the study period was significantly higher in the group using CCBs than in the
group using other antihypertensive agents (75% v. 59%). The adjusted odds ... Cited by 61 - Related articles - BL Direct - All 13 versions
F Amenta, F Mignini, F Rabbia, D Tomassoni, … - Journal of the neurological sciences, 2002 - Elsevier Hypertension is a risk factor for stroke and may also contribute to the
development of vascular cognitive impairment (VCI) and vascular dementia (VaD).
Cognitive complications of hypertension and the influence of ... Cited by 59 - Related articles - All 10 versions
SR Waldstein, JR Jennings, CM Ryan, MF … - Health Psychology, 1996 - psycnet.apa.org Potentially interactive effects of hypertension and age on the performance of
neuropsychological and information processing tests were examined in 123
untreated hypertensive and 50 normotensive men. After covarying education, ... Cited by 55 - Related articles - BL Direct - All 5 versions
EJ Pérez-Stable, R Halliday, PS Gardiner, … - The American journal of medicine, 2000 - Elsevier Drug therapy is recommended for most of the >50 million Americans with
hypertension. Beta-blockers are one of the two medications recommended as
first-step treatment for hypertension by the Fifth and Sixth Reports of the ... Cited by 44 - Related articles - BL Direct - All 7 versions
R Fogari, A Mugellini, A Zoppi, G Derosa, C … - Journal of human hypertension, 2003 - nature.com The aim of this study was to compare the effect of the beta-adrenergic blocker
atenolol and the Angiotensin II type 1 (AT1) receptor antagonist losartan on
cognitive function in very elderly hypertensive patients. A total of 120 ... Cited by 48 - Related articles - BL Direct - All 4 versions
JR Schneider, CA McHorney, DJ Malenka, MD … - Annals of Vascular Surgery, 1993 - Springer Functional health and sense of well-being are known to be adversely affected by
chronic illness. The extent to which peripheral vascular occlusive disease
(PVOD) alters these factors independent of other comorbid conditions is ... Cited by 39 - Related articles - BL Direct - All 7 versions
- ►ahajournals.org WB Stason, CH Schmid, D Niedzwiecki, GW … - Hypertension, 1997 - Am Heart Assoc Abstract Our objective was to compare cardiovascular event rates in patients
with mild or moderate hypertension who received nifedipine with active drug
controls. We performed a MEDLARS search using the MeSH heading ... Cited by 27 - Related articles - BL Direct - All 5 versions
MF Muldoon, SR Waldstein, CM Ryan, JR … - Journal of hypertension, 2002 - journals.lww.com Page 1. Effects of six anti-hypertensive medications on cognitive performance
Matthew F. Muldoona, Shari R. Waldsteinb, Christopher M. Ryanc, ... Cited by 26 - Related articles - BL Direct - All 5 versions
AE Fletcher, CJ Bulpitt, L Thijs, J Tuomilehto … - Journal of hypertension, 2002 - journals.lww.com Sponsorship: The Syst-Eur Trial was a concerted action of the BIOMED Research
Programme, sponsored by the European Union. The trial was sponsored by Bayer AG,
Wuppertal Germany. Study medication was donated by Bayer AG and Merck ... Cited by 21 - Related articles - BL Direct - All 3 versions
